Multi-analyte liquid biopsies for molecular pathway guided personalized treatment selection in advanced refractory cancers: A clinical utility pilot study

Darshana Patil, Dadasaheb Akolkar, Rajnish Nagarkar, Navin Srivastava, Vineet Datta, Sanket Patil, Sachin Apurwa, Ajay Srinivasan, Rajan Datar

Open source

DOI: 10.3389/fonc.2022.972322
Published: 2022-12-23
Container: Frontiers in Oncology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2022.972322,
  title = {Multi-analyte liquid biopsies for molecular pathway guided personalized treatment selection in advanced refractory cancers: A clinical utility pilot study},
  author = {Darshana Patil and Dadasaheb Akolkar and Rajnish Nagarkar and Navin Srivastava and Vineet Datta and Sanket Patil and Sachin Apurwa and Ajay Srinivasan and Rajan Datar},
  year = {2022},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2022.972322},
  url = {https://doi.org/10.3389/fonc.2022.972322}
}

RIS

TY  - JOUR
TI  - Multi-analyte liquid biopsies for molecular pathway guided personalized treatment selection in advanced refractory cancers: A clinical utility pilot study
AU  - Darshana Patil
AU  - Dadasaheb Akolkar
AU  - Rajnish Nagarkar
AU  - Navin Srivastava
AU  - Vineet Datta
AU  - Sanket Patil
AU  - Sachin Apurwa
AU  - Ajay Srinivasan
AU  - Rajan Datar
PY  - 2022
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2022.972322
UR  - https://doi.org/10.3389/fonc.2022.972322
ER  -

APA

Patil, D., Akolkar, D., Nagarkar, R., Srivastava, N., Datta, V., Patil, S., Apurwa, S., Srinivasan, A., & Datar, R. (2022). Multi-analyte liquid biopsies for molecular pathway guided personalized treatment selection in advanced refractory cancers: A clinical utility pilot study. Frontiers in Oncology. https://doi.org/10.3389/fonc.2022.972322

Source records

crossref · retrieved 2026-09-26T02:56:39.997Z